An interesting nugget from the UBS Group's equity-strategy team notes touches on an important theme for investors to monitor.

One thing seems clear – there is no silver bullet when it comes to market structure! We recently introduced our new Nasdaq Stockholm IPO Pulse. Today, we update the data for our pair of Nasdaq IPO ...

The crypto industry has a complex political game before it right now, and is largely split on the best strategy to enact the agenda it spent more than $100 million to move in the last election. The ...

WASHINGTON — Republicans' crypto market structure bill, which some lawmakers say could reshape finance well beyond the crypto sector, faced stiff opposition from key Democratic lawmakers in a House ...

U.S. House Republicans are seeking to fast-track two key crypto bills -- the stablecoin-focused Genius Act and the broader crypto market-structure Clarity Act -- by advancing them in a single ...

With Senate Republicans in the banking committee expected to vote on a market structure bill by the end of September, ...

Palantir announces its switch to Nasdaq starting Nov. 26, 2024. The Nasdaq-100 Index has seen 24 companies make the jump from NYSE in recent years—will Palantir be next? Special Access: Get Market ...

Kennedy called the crypto market bill “a full leap,” clashing with Tim Scott’s end-September push as Democrats and banks call ...

WASHINGTON — Despite promises from House leadership, bankers aren't going to get their biggest concerns about a pair of crypto bills addressed before lawmakers send them to President Donald Trump's ...

I maintain a Hold rating on Structure Therapeutics due to competitive pressures and lingering doubts about aleniglipron’s efficacy and data integrity. Aleniglipron’s tolerability could be a ...